Seibu Mochizuki
Overview
Explore the profile of Seibu Mochizuki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
949
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shimizu M, Ogawa K, Sasaki H, Uehara Y, Otsuka Y, Okumura H, et al.
Curr Ther Res Clin Exp
. 2014 Jun;
64(9):707-14.
PMID: 24944418
Background: Dihydropyridines (DHPs), a type of calcium channel blocker (CCB), are commonly prescribed for the treatment of hypertension and angina pectoris. DHPs act mainly on L-type calcium channels, essentially causing...
2.
Nagoshi T, Yoshimura M, Rosano G, Lopaschuk G, Mochizuki S
Curr Pharm Des
. 2011 Sep;
17(35):3846-53.
PMID: 21933140
The derangement of the cardiac energy substrate metabolism plays a key role in the pathogenesis of heart failure. The utilization of non-carbohydrate substrates, such as fatty acids, is the predominant...
3.
Ozasa H, Ayaori M, Iizuka M, Terao Y, Uto-Kondo H, Yakushiji E, et al.
Atherosclerosis
. 2011 Aug;
219(1):141-50.
PMID: 21862012
Objective: Pioglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, reportedly reduces cardiovascular events in diabetic patients. ATP cassette binding transporters (ABC) A1 and G1 are pivotal molecules for cholesterol efflux...
4.
Terao Y, Ayaori M, Ogura M, Yakushiji E, Uto-Kondo H, Hisada T, et al.
J Atheroscler Thromb
. 2011 Jun;
18(6):513-30.
PMID: 21636950
Aim: Reverse cholesterol transport (RCT) is a critical mechanism for the anti-atherogenic property of HDL. The inhibitory effect of the sulfonylurea agent (SUA) glibenclamide on ATP binding-cassette transporter (ABC) A1...
5.
Yoshida H, Rosano G, Shimizu M, Mochizuki S, Yoshimura M
Curr Pharm Des
. 2011 Apr;
17(11):1090-4.
PMID: 21449891
Women tend to develop hypertension later as they transition into menopause, and during and after menopause the development of hypertension in women is independent of age and body mass index...
6.
Itakura H, Nakaya N, Kusunoki T, Shimizu N, Hirai S, Mochizuki S, et al.
J Cardiol
. 2010 Nov;
57(1):77-88.
PMID: 21067897
Objective: This long-term event monitoring (LEM) study was designed to evaluate the long-term lipid-lowering efficacy and safety of fluvastatin (Lochol®, Novartis A.G.) along with the incidence of cardiac and other...
7.
Komukai K, Mochizuki S, Yoshimura M
Fundam Clin Pharmacol
. 2010 Jul;
24(6):687-98.
PMID: 20608988
Premenopausal women are protected to some extent from cardiovascular and kidney diseases. Because this protection weakens after menopause, sex hormones are believed to play an important role in the pathogenesis...
8.
Yoshida H, Shimizu M, Ikewaki K, Taniguchi I, Tada N, Yoshimura M, et al.
J Hypertens
. 2010 May;
28(6):1150-7.
PMID: 20467269
Objectives: The randomized Jikei Heart Study has demonstrated that the addition of valsartan to conventional treatments prevents more cardiovascular events in Japanese patients with hypertension. This substudy analyses the sex...
9.
Tribulova N, Seki S, Radosinska J, Kaplan P, Babusikova E, Knezl V, et al.
Can J Physiol Pharmacol
. 2009 Dec;
87(12):1120-9.
PMID: 20029549
Using whole-heart preparations, we tested our hypothesis that Ca(2+) handling is closely related to cell-to-cell coupling at the gap junctions and that both are critical for the development and particularly...
10.
Ishikawa T, Nakano Y, Endoh A, Kubota T, Suzuki T, Nakata K, et al.
J Cardiol
. 2009 Sep;
54(2):238-44.
PMID: 19782261
Background And Objectives: The incidence of definite stent thrombosis (ST) after use of drug-eluting stents (DES), as defined by the Academic Research Consortium, is known to be lower in Japan...